Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 3:19 AM
Ignite Modification Date:
2025-12-26 @ 1:58 AM
NCT ID:
NCT00324805
Group ID:
EG001
Title:
Arm II (Chemotherapy, Bevacizumab)
Description:
Patients receive chemotherapy as in Arm I. Patients also receive bevacizumab IV over 30-90 minutes on day 1. Treatment with bevacizumab repeats every 21 days for up to 1 year.
Bevacizumab: Given IV
Cisplatin: Given IV
Docetaxel: Given IV
Gemcitabine Hydrochloride: Given IV
Pemetrexed Disodium: Given IV
Vinorelbine: Given IV
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
563
Serious Number At Risk:
735
Other Number Affected:
509
Other Number At Risk:
735
Study:
NCT00324805
Results Section:
NCT00324805
Adverse Events Module:
NCT00324805